Biora Therapeutics, Inc.
BIORQ
$0.1174
-$0.0086-6.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.40M | 6.47M | -4.19M | -- | -73.45M |
| Total Depreciation and Amortization | 111.00K | 110.00K | 105.00K | -- | 125.00K |
| Total Amortization of Deferred Charges | 937.00K | 340.00K | 1.94M | -- | 369.00K |
| Total Other Non-Cash Items | 1.49M | -21.26M | -12.60M | -- | 59.16M |
| Change in Net Operating Assets | 7.13M | 3.40M | 2.25M | -- | 2.76M |
| Cash from Operations | -8.73M | -10.95M | -12.50M | -- | -11.03M |
| Capital Expenditure | -19.00K | -180.00K | -15.00K | -- | -1.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 20.00K | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 3.00M | -- | -- |
| Cash from Investing | -19.00K | -180.00K | 3.01M | -- | -1.00K |
| Total Debt Issued | 8.00M | 0.00 | 2.81M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 363.00K | 3.30M | 2.80M | -- | 181.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.74M | 2.34M | -513.00K | -- | -3.03M |
| Cash from Financing | 6.62M | 5.64M | 5.10M | -- | -2.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.13M | -5.50M | -4.39M | -- | -13.88M |
